guideline_id,guideline_text,asp_rule_id,asp_rule_text,asp_rule_index,total_asp_rules,rating,comment
1.1.1,"People with obstructive jaundice

For people with obstructive jaundice and suspected pancreatic cancer, offer a pancreatic protocol CT scan before draining the bile duct",1.1.1,"offer(""pancreatic protocol CT"") :- have(""obstructive jaundice""), suspected(""pancreatic cancer""), not drain(""bile duct"")",0,1,2,Probably should not have 'not' and split into another rule
1.1.2,"People with obstructive jaundice

If the diagnosis is still unclear, offer fluorodeoxyglucose-positron emission tomography/CT (FDG-PET/CT) and/or endoscopic ultrasound (EUS) with EUS-guided tissue sampling",1.1.2,"1{offer(""FDG-PET/CT""); offer(""EUS"", ""EUS-guided tissue sampling"")}2 :- have(""obstructive jaundice""), suspected(""pancreatic cancer""), offered(""pancreatic protocol CT""), findings(""pancreatic protocol CT"", ""unclear diagnosis"")",0,1,1,
1.1.3,"People with obstructive jaundice

Take a biliary brushing for cytology if:
• endoscopic retrograde cholangiopancreatography (ERCP) is being used to relieve the biliary obstruction and
• there is no tissue diagnosis.",1.1.3,"take(""biliary brushing"", ""cytology"") :- relieve(""biliary obstruction""), have(""no tissue diagnosis"")",0,1,3,ERCP is missing
1.1.4,"People without jaundice who have pancreatic abnormalities on imaging

Offer a pancreatic protocol CT scan to people with pancreatic abnormalities but no jaundice",1.1.4,"offer(""pancreatic protocol CT"") :- have(""pancreatic abnormalities""), not have(""jaundice"")",0,1,1,
1.1.5,"People without jaundice who have pancreatic abnormalities on imaging

If the diagnosis is still unclear, offer FDG-PET/CT and/or EUS with EUS-guided tissue sampling",1.1.5,"1{offer(""FDG-PET/CT""); offer(""EUS"", ""EUS-guided tissue sampling"")}2 :- have(""pancreatic abnormalities""), not have(""jaundice""), offered(""pancreatic protocol CT""), findings(""pancreatic protocol CT"", ""unclear diagnosis"")",0,1,1,
1.1.6,"People without jaundice who have pancreatic abnormalities on imaging

If cytological or histological samples are needed, offer EUS with EUS-guided tissue sampling",1.1.6,"offer(""EUS"", ""EUS-guided tissue sampling"") :- need(""cytological or histological samples"")",0,1,1,
1.1.7,"People with pancreatic cysts

Offer a pancreatic protocol CT scan or magnetic resonance cholangiopancreatography (MRI/MRCP) to people with pancreatic cysts. If more information is needed after one of these tests, offer the other one",1.1.7,"1{offer(""pancreatic protocol CT""); offer(""MRI/MRCP"")}1 :- have(""pancreatic cysts"")",0,3,1,
1.1.7,"People with pancreatic cysts

Offer a pancreatic protocol CT scan or magnetic resonance cholangiopancreatography (MRI/MRCP) to people with pancreatic cysts. If more information is needed after one of these tests, offer the other one",1.1.7_B,"offer(""MRI/MRCP"") :- have(""pancreatic cysts""), offered(""pancreatic protocol CT""), need(""more information"")",1,3,1,
1.1.7,"People with pancreatic cysts

Offer a pancreatic protocol CT scan or magnetic resonance cholangiopancreatography (MRI/MRCP) to people with pancreatic cysts. If more information is needed after one of these tests, offer the other one",1.1.7_C,"offer(""pancreatic protocol CT"") :- have(""pancreatic cysts""), offered(""MRI/MRCP""), need(""more information"")",2,3,1,
1.1.8,"People with pancreatic cysts

Refer people with any of these high-risk features for resection:
• obstructive jaundice with cystic lesions in the head of the pancreas
• enhancing solid component in the cyst
• a main pancreatic duct that is 10 mm diameter or larger.",1.1.8,"refer(""resection"") :- have(""obstructive jaundice""), have(""cystic lesions in the head of the pancreas"")",0,3,1,
1.1.8,"People with pancreatic cysts

Refer people with any of these high-risk features for resection:
• obstructive jaundice with cystic lesions in the head of the pancreas
• enhancing solid component in the cyst
• a main pancreatic duct that is 10 mm diameter or larger.",1.1.8_B,"refer(""resection"") :- have(""enhancing solid component in the cyst"")",1,3,1,
1.1.8,"People with pancreatic cysts

Refer people with any of these high-risk features for resection:
• obstructive jaundice with cystic lesions in the head of the pancreas
• enhancing solid component in the cyst
• a main pancreatic duct that is 10 mm diameter or larger.",1.1.8_C,"refer(""resection"") :- have(""main pancreatic duct that is 10 mm diameter or larger"")",2,3,1,
1.1.9,"People with pancreatic cysts

Offer EUS after CT and MRI/MRCP if more information on the likelihood of malignancy is needed, or if it is not clear whether surgery is needed",1.1.9,"offer(""EUS"") :- have(""pancreatic cysts""), offered(""pancreatic protocol CT""), offered(""MRI/MRCP""), need(""more information on the likelihood of malignancy"")",0,2,1,
1.1.9,"People with pancreatic cysts

Offer EUS after CT and MRI/MRCP if more information on the likelihood of malignancy is needed, or if it is not clear whether surgery is needed",1.1.9_B,"offer(""EUS"") :- have(""pancreatic cysts""), offered(""pancreatic protocol CT""), offered(""MRI/MRCP""), need(""unclear whether surgery is needed"")",1,2,1,
1.1.10,"People with pancreatic cysts

Consider fine-needle aspiration during EUS if more information on the likelihood of malignancy is needed",1.1.10,"consider(""EUS"", ""fine-needle aspiration"") :- need(""more information on the likelihood of malignancy"")",0,1,3,Missed pancreatic cysts
1.1.11,"People with pancreatic cysts

When using fine-needle aspiration, perform carcinoembryonic antigen (CEA) assay in addition to cytology if there is sufficient sample",1.1.11,"perform(""CEA assay"") :- offered(""fine-needle aspiration""), have(""sufficient sample"")",0,2,3,Missed pancreatic cysts
1.1.11,"People with pancreatic cysts

When using fine-needle aspiration, perform carcinoembryonic antigen (CEA) assay in addition to cytology if there is sufficient sample",1.1.11_B,"perform(""cytology"") :- offered(""fine-needle aspiration"")",1,2,3,Missed pancreatic cysts and sufficient sample
1.1.12,"People with pancreatic cysts

For people with cysts that are thought to be malignant, follow the recommendations on staging",,,0,0,0,Did not translate
1.1.13,"People with inherited high risk of pancreatic cancer

Ask people with pancreatic cancer if any of their first-degree relatives has had it",,,0,0,0,Did not translate
1.1.14,"People with inherited high risk of pancreatic cancer

Offer surveillance for pancreatic cancer to people with:
• hereditary pancreatitis and a PRSS1 mutation
• BRCA1, BRCA2, PALB2 or CDKN2A (p16) mutations, and one or more first-degree relatives with pancreatic cancer
• Peutz–Jeghers syndrome.",1.1.14,"offer(""surveillance"", ""pancreatic cancer"") :- have(""inherited high risk""), have(""hereditary pancreatitis""), have(""PRSS1"")",0,3,1,
1.1.14,"People with inherited high risk of pancreatic cancer

Offer surveillance for pancreatic cancer to people with:
• hereditary pancreatitis and a PRSS1 mutation
• BRCA1, BRCA2, PALB2 or CDKN2A (p16) mutations, and one or more first-degree relatives with pancreatic cancer
• Peutz–Jeghers syndrome.",1.1.14_B,"offer(""surveillance"", ""pancreatic cancer"") :- have(""inherited high risk""), 1{have(""BRCA1""); have(""BRCA2""); have(""PALB2""); have(""CDKN2A (p16)"")}4, first_degree_relative(""pancreatic cancer"", _)",1,3,1,
1.1.14,"People with inherited high risk of pancreatic cancer

Offer surveillance for pancreatic cancer to people with:
• hereditary pancreatitis and a PRSS1 mutation
• BRCA1, BRCA2, PALB2 or CDKN2A (p16) mutations, and one or more first-degree relatives with pancreatic cancer
• Peutz–Jeghers syndrome.",1.1.14_C,"offer(""surveillance"", ""pancreatic cancer"") :- have(""inherited high risk""), have(""Peutz–Jeghers syndrome"")",2,3,1,
1.1.15,"People with inherited high risk of pancreatic cancer

Consider surveillance for pancreatic cancer for people with:
• 2 or more first-degree relatives with pancreatic cancer, across 2 or more generations
• Lynch syndrome (mismatch repair gene [MLH1, MSH2, MSH6 or PMS2] mutations) and any first-degree relatives with pancreatic cancer.",1.1.15,"consider(""surveillance"", ""pancreatic cancer"") :- have(""inherited high risk""), first_degree_relative(""pancreatic cancer"", X), first_degree_relative(""pancreatic cancer"", Y), X!=Y",0,2,1,
1.1.15,"People with inherited high risk of pancreatic cancer

Consider surveillance for pancreatic cancer for people with:
• 2 or more first-degree relatives with pancreatic cancer, across 2 or more generations
• Lynch syndrome (mismatch repair gene [MLH1, MSH2, MSH6 or PMS2] mutations) and any first-degree relatives with pancreatic cancer.",1.1.15_B,"consider(""surveillance"", ""pancreatic cancer"") :- have(""inherited high risk""), have(""Lynch syndrome""), first_degree_relative(""pancreatic cancer"", _)",1,2,1,
1.1.16,"People with inherited high risk of pancreatic cancer

Consider an MRI/MRCP or EUS for pancreatic cancer surveillance in people without hereditary pancreatitis",1.1.16,"1{consider(""MRI/MRCP""); consider(""EUS"")}1 :- have(""inherited high risk""), not have(""hereditary pancreatitis"")",0,1,1,
1.1.17,"People with inherited high risk of pancreatic cancer

Consider a pancreatic protocol CT scan for pancreatic cancer surveillance in people with hereditary pancreatitis and a PRSS1 mutation",1.1.17,"consider(""pancreatic protocol CT"") :- have(""inherited high risk""), have(""hereditary pancreatitis""), have(""PRSS1"")",0,1,1,
1.1.18,"People with inherited high risk of pancreatic cancer

Do not offer EUS to detect pancreatic cancer in people with hereditary pancreatitis",1.1.18,":- have(""inherited high risk""), offer(""EUS""), have(""hereditary pancreatitis"")",0,1,1,
1.2.4,"Pancreatic cancer

Refer people using a suspected cancer pathway referral for pancreatic cancer if they are aged 40 and over and have jaundice",1.2.4,"refer(""suspected cancer pathway referral"", ""pancreatic cancer"") :- age(X), X>=40, have(""jaundice"")",0,1,1,
1.2.5,"Pancreatic cancer

Consider an urgent, direct access CT scan (to be done within 2 weeks), or an urgent ultrasound scan if CT is not available, to assess for pancreatic cancer in people aged 60 and over with weight loss and any of the following:
•	diarrhoea
•   back pain
•   abdominal pain
•   nausea
•   vomiting
•   constipation
•   new-onset diabetes.",1.2.5,"consider(""CT"") :- age(X), X>=60, have(""weight loss""), 1{have(""diarrhoea""); have(""back pain""); have(""abdominal pain""); have(""nausea""); have(""vomiting""); have(""constipation""); have(""new-onset diabetes"")}7",0,2,1,
1.2.5,"Pancreatic cancer

Consider an urgent, direct access CT scan (to be done within 2 weeks), or an urgent ultrasound scan if CT is not available, to assess for pancreatic cancer in people aged 60 and over with weight loss and any of the following:
•	diarrhoea
•   back pain
•   abdominal pain
•   nausea
•   vomiting
•   constipation
•   new-onset diabetes.",1.2.5_B,"consider(""ultrasound"") :- age(X), X>=60, have(""weight loss""), 1{have(""diarrhoea""); have(""back pain""); have(""abdominal pain""); have(""nausea""); have(""vomiting""); have(""constipation""); have(""new-onset diabetes"")}7, not available(""CT"")",1,2,1,
1.3.1,"For people with newly diagnosed pancreatic cancer who have not had a pancreatic protocol CT scan, offer a pancreatic protocol CT scan that includes the chest, abdomen and pelvis",1.3.1,"offer(""pancreatic protocol CT"") :- have(""pancreatic cancer""), not offered(""pancreatic protocol CT"")",0,1,3,"Missing information on chest, abdomen and pelvis"
1.3.2,"Offer fluorodeoxyglucose-positron emission tomography/CT (FDG-PET/CT) to people with localised disease on CT who will be having cancer treatment (surgery, radiotherapy or systemic therapy)",1.3.2,"offer(""FDG-PET/CT"") :- have(""localised disease""), 1{offer(""surgery""); offer(""radiotherapy""); offer(""systemic therapy"")}3",0,1,1,
1.3.3,"If more information is needed to decide the person's clinical management, consider one or more of the following:
• MRI, for suspected liver metastases
• endoscopic ultrasound, if more information is needed for tumour and node staging
• laparoscopy with laparoscopic ultrasound, for suspected small-volume peritoneal and/or liver metastases if resectional surgery is a possibility.",1.3.3,"consider(""MRI"") :- suspected(""liver metastases""), need(""more information"")",0,4,1,
1.3.3,"If more information is needed to decide the person's clinical management, consider one or more of the following:
• MRI, for suspected liver metastases
• endoscopic ultrasound, if more information is needed for tumour and node staging
• laparoscopy with laparoscopic ultrasound, for suspected small-volume peritoneal and/or liver metastases if resectional surgery is a possibility.",1.3.3_B,"consider(""EUS"") :- need(""more information""), need(""tumour and node staging"")",1,4,1,
1.3.3,"If more information is needed to decide the person's clinical management, consider one or more of the following:
• MRI, for suspected liver metastases
• endoscopic ultrasound, if more information is needed for tumour and node staging
• laparoscopy with laparoscopic ultrasound, for suspected small-volume peritoneal and/or liver metastases if resectional surgery is a possibility.",1.3.3_C,"consider(""laparoscopy"", ""laparoscopic ultrasound"") :- suspected(""peritoneal""), offer(""resectional surgery"")",2,4,1,
1.3.3,"If more information is needed to decide the person's clinical management, consider one or more of the following:
• MRI, for suspected liver metastases
• endoscopic ultrasound, if more information is needed for tumour and node staging
• laparoscopy with laparoscopic ultrasound, for suspected small-volume peritoneal and/or liver metastases if resectional surgery is a possibility.",1.3.3_D,"consider(""laparoscopy"", ""laparoscopic ultrasound"") :- suspected(""liver metastases""), offer(""resectional surgery"")",3,4,1,
1.13.2,"For people with unexplained weight loss, which is a symptom of several cancers including colorectal, gastro-oesophageal, lung, prostate, pancreatic and urological cancer:
•	carry out an assessment for additional symptoms, signs or findings that may help to clarify which cancer is most likely and
•	offer urgent investigation or a suspected cancer pathway referral.",1.13.2,"assess(""additional symptoms"") :- have(""weight loss"", ""unexplained"")",0,2,1,
1.13.2,"For people with unexplained weight loss, which is a symptom of several cancers including colorectal, gastro-oesophageal, lung, prostate, pancreatic and urological cancer:
•	carry out an assessment for additional symptoms, signs or findings that may help to clarify which cancer is most likely and
•	offer urgent investigation or a suspected cancer pathway referral.",1.13.2_B,"1{offer(""urgent investigation""); offer(""suspected cancer pathway referral"")}1 :- have(""weight loss"", ""unexplained"")",1,2,1,
1.13.3,"For people with unexplained appetite loss, which is a symptom of several cancers including lung, oesophageal, stomach, colorectal, pancreatic, bladder and renal cancer:
•	carry out an assessment for additional symptoms, signs or findings that may help to clarify which cancer is most likely and
•	offer urgent investigation or a suspected cancer pathway referral.",1.13.3,"assess(""additional symptoms"") :- have(""appetite loss"", ""unexplained"")",0,2,1,
1.13.3,"For people with unexplained appetite loss, which is a symptom of several cancers including lung, oesophageal, stomach, colorectal, pancreatic, bladder and renal cancer:
•	carry out an assessment for additional symptoms, signs or findings that may help to clarify which cancer is most likely and
•	offer urgent investigation or a suspected cancer pathway referral.",1.13.3_B,"1{offer(""urgent investigation""); offer(""suspected cancer pathway referral"")}1 :- have(""appetite loss"", ""unexplained"")",1,2,1,
